These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11816893)

  • 1. Autoimmune inner ear disease: steroid and cytotoxic drug therapy.
    Lasak JM; Sataloff RT; Hawkshaw M; Carey TE; Lyons KM; Spiegel JR
    Ear Nose Throat J; 2001 Nov; 80(11):808-11, 815-6, 818 passim. PubMed ID: 11816893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open trial of methotrexate as treatment for autoimmune hearing loss.
    Matteson EL; Fabry DA; Facer GW; Beatty CW; Driscoll CL; Strome SE; McDonald TJ
    Arthritis Rheum; 2001 Apr; 45(2):146-50. PubMed ID: 11324778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.
    Street I; Jobanputra P; Proops DW
    J Laryngol Otol; 2006 Dec; 120(12):1064-6. PubMed ID: 17040588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate therapy for autoimmune hearing loss: a preliminary report.
    Sismanis A; Thompson T; Willis HE
    Laryngoscope; 1994 Aug; 104(8 Pt 1):932-4. PubMed ID: 8052076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
    Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss.
    Choung YH; Park K; Shin YR; Cho MJ
    Laryngoscope; 2006 May; 116(5):747-52. PubMed ID: 16652082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-mediated inner ear disease: 10-year experience.
    Broughton SS; Meyerhoff WE; Cohen SB
    Semin Arthritis Rheum; 2004 Oct; 34(2):544-8. PubMed ID: 15505770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N; Quartuccio L; De Marchi G; De Vita S
    Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated inner ear disorders.
    Moscicki RA
    Baillieres Clin Neurol; 1994 Nov; 3(3):547-63. PubMed ID: 7874408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.
    García Berrocal JR; Ramírez-Camacho R; Arellano B; Vargas JA
    Laryngoscope; 2002 Feb; 112(2):304-9. PubMed ID: 11889388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss.
    Harris JP; Sharp PA
    Laryngoscope; 1990 May; 100(5):516-24. PubMed ID: 2329911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of pharmacologic therapy combined with hyperbaric oxygen in sensorineural hearing loss following acute acoustic trauma. Preliminary report].
    Winiarski M; Kantor I; Smereka J; Jurkiewicz D
    Pol Merkur Lekarski; 2005 Sep; 19(111):348-50. PubMed ID: 16358866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment.
    Van Wijck F; Staecker H; Lefebvre PP
    Acta Otolaryngol; 2007 Oct; 127(10):1012-7. PubMed ID: 17851934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
    Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
    Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic findings and therapeutic results in chronic progressive inner ear hearing loss].
    Kempf HG; Hörnig T
    HNO; 1987 Jan; 35(1):38-42. PubMed ID: 3549637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune inner ear disease in children.
    Huang NC; Sataloff RT
    Otol Neurotol; 2011 Feb; 32(2):213-6. PubMed ID: 21178803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis and treatment of sudden sensorineural hearing loss.
    Fetterman BL; Saunders JE; Luxford WM
    Am J Otol; 1996 Jul; 17(4):529-36. PubMed ID: 8841697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
    Harris JP; Weisman MH; Derebery JM; Espeland MA; Gantz BJ; Gulya AJ; Hammerschlag PE; Hannley M; Hughes GB; Moscicki R; Nelson RA; Niparko JK; Rauch SD; Telian SA; Brookhouser PE
    JAMA; 2003 Oct; 290(14):1875-83. PubMed ID: 14532316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-refractory autoimmune sensorineural hearing loss: response to infliximab.
    Liu YC; Rubin R; Sataloff RT
    Ear Nose Throat J; 2011 Jan; 90(1):23-8. PubMed ID: 21229506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.